Sunday 11 October 2026
Export all ITRI data to Excel Powerpack
Itron, Inc.
ITRI Technology Scientific & Technical Instruments
Itron, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, down 3.02% from fiscal 2024. In the quarter to June 2026, revenue fell 7.23%, EPS fell 19.3%, free cash flow fell 10.1% and total debt rose 26.5%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
85.58
1.35
+1.60%
Follow ITRI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
14.21 | 14.05 | 14.03 | 22.01 |
+8 more quarters Free account |
P/S ratio |
1.66 | 1.71 | 1.78 | 2.37 | |
P/FCF ratio |
9.90 | 10.16 | 11.03 | 16.67 | |
P/Operating CF |
43.31 | 46.89 | 35.40 | 48.36 | |
P/B ratio |
2.33 | 2.46 | 2.43 | 3.33 | |
Price to Tangible BV |
0.00 | 0.00 | 13.63 | 9.57 | |
EV/Sales |
2.22 | 2.27 | 1.88 | 2.33 | |
EV/EBITDA |
13.65 | 14.50 | 12.04 | 15.77 | |
EV/Operating CF |
12.43 | 12.71 | 10.97 | 15.32 | |
EV/FCF |
13.25 | 13.51 | 11.62 | 16.43 | |
Quick Ratio |
1.94 | 1.93 | 1.37 | 1.72 | |
Current Ratio |
2.75 | 2.66 | 1.80 | 2.17 | |
Net Debt/EBITDA |
8.59 | 9.79 | 2.43 | (0.89) | |
Debt/Assets |
39.44% | 39.56% | 33.55% | 33.60% | |
Debt/Equity |
0.96 | 0.97 | 0.72 | 0.73 | |
Asset Turnover |
0.60 | 0.63 | 0.66 | 0.68 | |
Operating CF/Net income |
1.65 | 1.60 | 1.17 | 1.80 | |
Capex/Depreciation |
(0.32) | (0.32) | (0.52) | (0.32) | |
Interest Coverage |
13.19 | 11.63 | 14.14 | 14.48 | |
Research and Development Expense of Revenue |
9.97% | 9.37% | 9.29% | 8.60% | |
Selling, General and Administrative Expense of Revenue |
15.94% | 17.95% | 16.67% | 14.29% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.38 | 0.30 | |
Share Based Compensation of Revenue |
2.18% | 3.42% | 2.56% | 2.48% | |
Graham Net Nets |
(0.21) | (0.21) | (0.04) | 0.03 | |
Graham Number |
71.35 | 72.30 | 75.44 | 69.06 | |
Earnings Yield |
7.04% | 7.12% | 7.13% | 4.54% | |
Free Cash Flow Yield |
10.10% | 9.84% | 9.07% | 6.00% | |
Revenue per Share |
12.77 | 13.12 | 12.57 | 12.71 | |
Operating CF per Share |
2.00 | 1.91 | 2.62 | 2.58 | |
Capex per Share |
(0.15) | (0.15) | (0.17) | (0.10) | |
Free Cash Flow per Share |
1.85 | 1.77 | 2.45 | 2.48 | |
Cash per Share |
16.90 | 15.94 | 22.43 | 29.12 | |
Shareholders Equity per Share |
37.15 | 36.41 | 38.21 | 37.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.15 | 36.41 | 38.21 | 37.46 | |
Free Cash Flow |
81.49 | 78.97 | 111.51 | 113.41 | |
Working Capital |
985.30 | 951.06 | 810.09 | 1,156.66 | |
Capital Expenditures |
(6.60) | (6.53) | (7.81) | (4.42) | |
Net Current Asset Value |
(805.90) | (824.57) | (160.19) | 146.69 | |
EV/EBIT |
16.79 | 17.51 | 14.22 | 18.89 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
12.55 | 13.17 | 13.49 | 19.18 | |
| Other line items | |||||
Average Receivables |
345.72 | 369.88 | 359.13 | 354.14 | |
Average Payables |
134.93 | 168.67 | 150.61 | 148.92 | |
Average Inventory |
271.01 | 260.89 | 256.81 | 265.95 | |
Average Assets |
3,808.66 | 3,740.67 | 3,564.17 | 3,538.09 | |
Average Common Equity |
1,636.28 | 1,569.01 | 1,574.81 | 1,541.05 |
Columns are period end dates